Drug Prices
Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging
Drug Prices
Congress Grills Major Drug Manufacturer on Anticompetitive Tactics and Price Gouging
COVID-19 Vaccines are Evidence that Government Intervention Works
Drug Prices
COVID-19 Vaccines are Evidence that Government Intervention Works
Op-Ed
President Biden Called on Congress to Lower Drug Prices. What’s Next?
Drug Prices
President Biden Called on Congress to Lower Drug Prices. What’s Next?
New Laws Take Aim at Drug Prices, But Stronger Action Needed
Drug Prices
New Laws Take Aim at Drug Prices, But Stronger Action Needed
After Sluggish Start, Is the Biosimilar Market Poised for Growth?
Drug Prices
After Sluggish Start, Is the Biosimilar Market Poised for Growth?
Drug Pricing Reform Enters a Big, New Battleground: States
Drug Prices
Drug Pricing Reform Enters a Big, New Battleground: States
Landmark SCOTUS Ruling Opens the Door for Stronger State Regulation of PBMs
Drug Prices
Landmark SCOTUS Ruling Opens the Door for Stronger State Regulation of PBMs
A Drug is 90 Percent Effective at Preventing HIV. It Costs Up to $1,800 Per Month.
Drug Prices
A Drug is 90 Percent Effective at Preventing HIV. It Costs Up to $1,800 Per Month.
5 Ways to Reform Health Care in 2021
Drug Prices
5 Ways to Reform Health Care in 2021
The Biden Administration
In Day 2 of Testimony, Pharma Execs Struggle to Answer Tough Questions on Unsustainable Drug Prices
Drug Prices
In Day 2 of Testimony, Pharma Execs Struggle to Answer Tough Questions on Unsustainable Drug Prices
Pharma’s Bad Behaviors Exposed in Congressional Testimony
Drug Prices
Pharma’s Bad Behaviors Exposed in Congressional Testimony
'Evergreening' Stunts Competition, Costs Consumers and Taxpayers
Drug Prices
‘Evergreening’ Stunts Competition, Costs Consumers and Taxpayers
President Trump’s 'Most Favored Nation' Executive Order Won’t Lower Drug Prices Immediately
Drug Prices
President Trump’s ‘Most Favored Nation’ Executive Order Won’t Lower Drug Prices Immediately
Broadly Used Data Source May Result in Inaccurate Estimates of Drug Prices
Drug Prices
Broadly Used Data Source May Result in Inaccurate Estimates of Drug Prices
'Canary in a Coal Mine': Expensive Brand-Name Drugs Thrive in Medicare Part D Despite Generic Competition, Driving Up Costs
Drug Prices
‘Canary in a Coal Mine’: Expensive Brand-Name Drugs Thrive in Medicare Part D Despite Generic Competition, Driving Up Costs
'Buy American' Rule Aimed at Lessening Dependence on Foreign Drug Manufacturing Could Lead to Higher Prices
Drug Prices
‘Buy American’ Rule Aimed at Lessening Dependence on Foreign Drug Manufacturing Could Lead to Higher Prices
Explainer
A Letter to CMS on the Proposed Medicaid Rule
Drug Prices
A Letter to CMS on the Proposed Medicaid Rule
Executive Orders Unlikely to Lower Drug Prices
Drug Prices
Executive Orders Unlikely to Lower Drug Prices
To Lower Drug Costs, Tap Pharmacists for Help
Drug Prices
To Lower Drug Costs, Tap Pharmacists for Help
A Reflection on the Biosimilar Pathway As it Turns 10 Years Old
Drug Prices
A Reflection on the Biosimilar Pathway As it Turns 10 Years Old
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.